KEY PRODUCTS
Maithri Drugs: Dedicated to your API needs.
01 1Maithri Drugs
01 1METHIMAZOLE USP
01 1India
01 1Active
01 1Complete
Maithri Drugs: Dedicated to your API needs.
GDUFA
DMF Review : Complete
Rev. Date : 2023-03-21
Pay. Date : 2023-01-31
DMF Number : 36643
Submission : 2021-12-29
Status : Active
Type : II
20
Maithri Drugs Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Maithri Drugs: Dedicated to your API needs.
One of their notable products is METHIMAZOLE USP, with a corresponding US DMF Number 36643.
Remarkably, this DMF maintains an Active status since its submission on December 29, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 21, 2023, and payment made on January 31, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
